SOLICITATION NOTICE
68 -- EYLEA Single Use Vial Kits - Statement of Work
- Notice Date
- 8/20/2018
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, Clinical Center/Office of Purchasing & Contracts, 6707 Democracy Blvd, Suite 106, MSC 5480, Bethesda, Maryland, 20892-5480
- ZIP Code
- 20892-5480
- Solicitation Number
- NIH-CC-18-010494
- Archive Date
- 9/20/2018
- Point of Contact
- Lisa L. Schaupp, Phone: 3014020735
- E-Mail Address
-
Lisa.Schaupp@nih.gov
(Lisa.Schaupp@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Pricing Table - including Option Periods EYLEA Single Use Vial Kits - Statement of Work Solicitation Number: 18-010494 Notice Type: Combined Synopsis/Solicitation Synopsis: (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR 12 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued. This acquisition is not set aside for small businesses only. (ii) The solicitation number is 18-010494 and the solicitation is issued as a request for quote (RFQ). Offerors shall submit their quotes no later than 11:00 a.m. Eastern Time (ET) on Wednesday September 5, 2018. (iii) The solicitation document, the incorporated provisions and clauses are those in the Federal Acquisition Circular 2005-99-1, effective July 16, 2018. (iv) The associated North American Industry Classification System (NAICS) code for this procurement is 325412 and the small business size standard is 750 employees. The acquisition is being conducted in accordance with the procedures of FAR Part 12, in conjunction with FAR 13.5. PURPOSE: The purpose of this requirement is for the vendor to provide EYLEA (Aflibercept Injection) single use vial kits for human use for NIH Clinical Center patient care. (v) Background: CONTRACTOR REQUIREMENTS: See Attachment Number 1: Statement of Work See Attachment Number 2: Price Quote (vi) Period of Performance: Base Period: September 15, 2018 through September 14, 2019 Option Period 1: September 15, 2019 through September 14, 2020 Option Period 2: September 15, 2020 through September 14, 2021 Option Period 3: September 15, 2021 through September 14, 2022 Option Period 4: September 15, 2022 through September 14, 2023 (vii) The provision FAR clause 52.212-1, Instructions to Offerors - Commercial Items, applies to this acquisition and is hereby incorporated by reference. (vii) The provision at FAR clause 52.212-2, Evaluation - Commercial Items, applies to this acquisition and is hereby incorporated by reference. Quotes will be evaluated in accordance with FAR 52.212-2. Technical is more important than price. Technical capability will evaluated based on meeting or exceeding the requirement in the Statement of Work. Past performance will be evaluated on 3 references. Price will be evaluated on a fair and reasonable basis. Options will be evaluated in accordance with FAR Clause 52.217-5, Evaluation of Options. (viii) In accordance with FAR Clause 52.212-3, Offeror Representations and Certifications - Commercial Items, Offerors must complete annual representations and certifications on-line at https://www.sam.gov/portal/public/SAM/. (ix) FAR clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. (x) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items, applies to this acquisition. (xi) The Defense Priorities and Allocations System (DPAS) and assigned rating does not apply to this acquisition. Offerors shall submit their questions no later than 11:00 a.m., Eastern Time (ET) on Tuesday August 28, 2018. Offerors shall submit their quotations no later than 11:00 a.m., Eastern Time (EST) on Wednesday September 5, 2018. The quote must reference the Solicitation Number: 18-010494. All responsible offerors may submit a proposal, which if timely received, shall be considered by the agency. Quotes must be emailed to the Contract Specialist, Lisa Schaupp at Lisa.Schaupp@nih.gov. Quotations shall not be deemed received by the Government until the quotation is entered into the e-mail address inbox set forth above. Faxed proposals will NOT be accepted. PROVISIONS AND CLAUSES ADDENDUM TO 52.212-4 FAR 52.217-6, Option for Additional Quantities FAR 52.217-9, Option to Extend the Term of the Contract FAR 52.216-2 -- Economic Price Adjustment -- Standard Supplies (Jan 1997) Addendum to FAR 52.212-1, Proposal Preparation Instructions FAR 52.212-1 is hereby amended to reflect the changes shown below as to the specific paragraph revised. (1) ELECTRONIC OFFERS. The offeror shall submit electronic offers in response to this solicitation unless otherwise specified herein. The offer must arrive by the time specified in the solicitation to the following email address: Lisa.Schaupp@nih.gov. (2) PROCESS FOR AWARD. Award will be made to the Offeror consistent with the evaluation criteria discussed at FAR 52.212-2 and Addendum to FAR 52.212-2. (3) BASIS FOR AWARD. Award will be made to the offeror that proposes: a technical proposal conforming to the requirements of the solicitation; has an acceptable record of past performance; its price is determined to be fair and reasonable by the contracting officer; and the contracting officer determines the offeror is responsible in accordance with FAR Part 9. • Contract Line Item Numbers (CLINS). Provide pricing for each CLIN. • Copy of Schedule Contract and terms and conditions, if applicable • Proof to distribute/Resell as authorized distributor/reseller to provide the item(s) by submitting documentation from the manufacture (if applicable); • Failure to provide proof to distribute/resell the original manufacture's pharmaceutical may cause your offer to be rejected and not considered further for award.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/CCOPC/NIH-CC-18-010494/listing.html)
- Place of Performance
- Address: NIH Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN05045355-W 20180822/180820231109-5130a28005724d2e04985ac8d76281c9 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |